Tahl Cindy's Form 4 filing
Fate Therapeutics Inc (FATE) · filed Jul 2, 2021
- Accession no.
- 0001209191-21-045182
- Filed
- Jul 2, 2021
- Trade date
- Jul 1, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 15 non-derivative transactions and 4 derivative transactions. Open-market sales total $4.73M. It was filed 1 day after the trade.
This filing was later replaced by the amendment 0000899243-22-003421 (Jan 27, 2022). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tahl CindyCIK 0001655472 | Officer (General Counsel and Secretary) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2021 | Common Stock | MOption exerciseAcquired | +5,534 | $7.87 | +$43,552.58 | 113,582 | Direct | |
| Jul 1, 2021 | Common Stock | MOption exerciseAcquired | +6,932 | $4.84 | +$33,550.88 | 120,514 | Direct | |
| Jul 1, 2021 | Common Stock | MOption exerciseAcquired | +27,685 | $4.89 | +$135,379.65 | 148,199 | Direct | |
| Jul 1, 2021 | Common Stock | MOption exerciseAcquired | +15,383 | $6.55 | +$100,758.65 | 163,582 | Direct | |
| Jul 1, 2021 | Common Stock | SSaleDisposed | −100 | $84.83 | −$8,483 | 163,482 | Direct | |
| Jul 1, 2021 | Common Stock | SSaleDisposed | −200 | $86.56F3 | −$17,312 | 163,282 | Direct | |
| Jul 1, 2021 | Common Stock | SSaleDisposed | −1,145 | $87.90F4 | −$100,645.5 | 162,137 | Direct | |
| Jul 1, 2021 | Common Stock | SSaleDisposed | −400 | $88.93F5 | −$35,572 | 161,737 | Direct | |
| Jul 1, 2021 | Common Stock | SSaleDisposed | −707 | $90.30F6 | −$63,842.1 | 161,030 | Direct | |
| Jul 1, 2021 | Common Stock | SSaleDisposed | −225 | $91.06F7 | −$20,488.5 | 160,805 | Direct | |
| Jul 1, 2021 | Common Stock | SSaleDisposed | −432 | $92.26F8 | −$39,856.32 | 160,373 | Direct | |
| Jul 1, 2021 | Common Stock | SSaleDisposed | −400 | $93.31F9 | −$37,324 | 159,973 | Direct | |
| Jul 1, 2021 | Common Stock | SSaleDisposed | −1,825 | $94.63F10 | −$172,699.75 | 158,148 | Direct | |
| Jul 1, 2021 | Common Stock | SSaleDisposed | −100 | $95.30 | −$9,530 | 158,048 | Direct | |
| Jul 1, 2021 | Common Stock | SSaleDisposed | −50,000 | $84.56 | −$4,228,000 | 108,048 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2021 | Common Stock | MOption exerciseDisposed | −5,534 | $0.00 | $0 | 0 | Direct | |
| Jul 1, 2021 | Common Stock | MOption exerciseDisposed | −6,932 | $0.00 | $0 | 27,628 | Direct | |
| Jul 1, 2021 | Common Stock | MOption exerciseDisposed | −27,685 | $0.00 | $0 | 22,315 | Direct | |
| Jul 1, 2021 | Common Stock | MOption exerciseDisposed | −15,383 | $0.00 | $0 | 166,643 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Represents the weighted average sale price of the shares sold ranging from $86.47 to $86.65 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 3 through 10.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average sale price of the shares sold ranging from $87.50 to $88.28 per share.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average sale price of the shares sold ranging from $88.65 to $89.48 per share.
Referenced by the price of 1 transaction in Table I.
- F6
Represents the weighted average sale price of the shares sold ranging from $89.78 to $90.68 per share.
Referenced by the price of 1 transaction in Table I.
- F7
Represents the weighted average sale price of the shares sold ranging from $90.81 to $91.64 per share.
Referenced by the price of 1 transaction in Table I.
- F8
Represents the weighted average sale price of the shares sold ranging from $91.88 to $92.41 per share.
Referenced by the price of 1 transaction in Table I.
- F9
Represents the weighted average sale price of the shares sold ranging from $93.21 to $93.54 per share.
Referenced by the price of 1 transaction in Table I.
- F10
Represents the weighted average sale price of the shares sold ranging from $94.22 to $95.12 per share.
Referenced by the price of 1 transaction in Table I.
Remarks
General Counsel and Secretary